• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Dec 14, 2016
Clinical News

Vosoritide: Ph III started

Read More
BioCentury | Apr 21, 2016
Clinical News

BioMarin updates plans for three late-stage programs

Read More
BioCentury | Apr 21, 2016
Top Story

First clinical data for BioMarin hemo A gene therapy

Read More
BioCentury | Jan 11, 2016
Finance

Sowing season

Buysiders eyeing big cap clinical milestones in 2016 to seed next growth spurt
Read More
BioCentury | Sep 7, 2015
Finance

Clinical payday

Why BioMarin parted with a Phase III PARP inhibitor
Read More
BioCentury | Jul 13, 2015
Finance

Big news

Biotech names and milestones investors like heading into 2H15
Read More
BioCentury | Jun 22, 2015
Clinical News

Vosoritide: Phase II data

Read More
BioCentury | Jun 19, 2015
Clinical News

BioMarin shares spike on dwarfism data

Read More
BioCentury | Jun 18, 2015
Top Story

BioMarin gains on Phase II achondroplasia data

Read More
BioCentury | Apr 6, 2015
Finance

Q is for quiet

Investors look for cancer immunotherapy combination, gene therapy data in 2Q15
Read More
Items per page:
1 - 10 of 22